Department of Chemistry, Rice University, Houston, Texas 77005-1892, USA.
J Chem Phys. 2019 Apr 21;150(15):155101. doi: 10.1063/1.5088647.
ERK2 is a kinase protein that belongs to a Ras/Raf/MEK/ERK signaling pathway, which is activated in response to a range of extracellular signals. Malfunctioning of this cascade leads to a variety of serious diseases, including cancers. This is often caused by mutations in proteins belonging to the cascade, frequently leading to abnormally high activity of the cascade even in the absence of an external signal. One such "gain-of-function" mutation in the ERK2 protein, called a "sevenmaker" mutation (D319N), was discovered in 1994 in Drosophila. The mutation leads to disruption of interactions of other proteins with the D-site of ERK2 and results, contrary to expectations, in an increase of its activity in vivo. However, no molecular mechanism to explain this effect has been presented so far. The difficulty is that this mutation should equally negatively affect interactions of ERK2 with all substrates, activators, and deactivators. In this paper, we present a semiquantitative kinetic network model that gives a possible explanation of the increased activity of mutant ERK2 species. A simplified biochemical network for ERK2, viewed as a system of coupled Michaelis-Menten processes, is presented. Its dynamic properties are calculated explicitly using the method of first-passage processes. The effect of mutation is associated with changes in the strength of interaction energy between the enzyme and the substrates. It is found that the dependence of kinetic properties of the protein on the interaction energy is nonmonotonic, suggesting that some mutations might lead to more efficient catalytic properties, despite weakening intermolecular interactions. Our theoretical predictions agree with experimental observations for the sevenmaker mutation in ERK2. It is also argued that the effect of mutations might depend on the concentrations of substrates.
ERK2 是一种激酶蛋白,属于 Ras/Raf/MEK/ERK 信号通路,该通路在响应一系列细胞外信号时被激活。该级联的功能障碍会导致多种严重疾病,包括癌症。这通常是由于级联中属于蛋白质的突变引起的,这些突变经常导致级联的异常高活性,即使在没有外部信号的情况下也是如此。ERK2 蛋白中的一种这样的“功能获得”突变,称为“七聚体”突变(D319N),于 1994 年在果蝇中发现。该突变导致其他蛋白质与 ERK2 的 D 位的相互作用中断,结果与预期相反,导致其在体内活性增加。然而,迄今为止尚未提出解释这种效应的分子机制。困难在于,这种突变应该同样对 ERK2 与所有底物、激活剂和失活剂的相互作用产生负面影响。在本文中,我们提出了一个半定量的动力学网络模型,该模型为突变型 ERK2 物种活性增加提供了可能的解释。提出了一个简化的 ERK2 生化网络,将其视为耦合米氏酶过程的系统。使用首次通过过程的方法显式计算其动态特性。突变的影响与酶与底物之间的相互作用能强度的变化有关。研究发现,蛋白质的动力学性质对相互作用能的依赖性是非单调的,这表明尽管减弱了分子间相互作用,但某些突变可能导致更有效的催化性质。我们的理论预测与 ERK2 中七聚体突变的实验观察结果一致。还认为突变的影响可能取决于底物的浓度。